Optimizing locoregional control and survival for women with breast cancer: A review of current developments in postmastectomy radiotherapy

Expert Review of Anticancer Therapy

Volumn 6, Issue 2, 2006, Pages 205-216

  Truong, Pauline T ^a   Woodward, Wendy A ^b   Buchholz, Thomas A ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; Locoregional control; Mastectomy; Rradiotherapy; Survival

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TAXANE DERIVATIVE;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; ERYTHEMA; FATIGUE; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; LUNG TOXICITY; LYMPH NODE METASTASIS; LYMPHEDEMA; MASTECTOMY; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PNEUMONIA; POSTMENOPAUSE; POSTOPERATIVE CARE; PREMENOPAUSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33644871031     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.6.2.205     Document Type: Review

References (58)

1. Cuzick J, Stewart H, Peto R et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat. Rep. 71, 15-29 (1987).
2. Cuzick J, Stewart H, Rutqvist L et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J. Clin. Oncol. 12, 447-453 (1994).
3. Arriagada R, Rutqvist LE, Mattsson A, Kramer A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J. Clin. Oncol. 13, 2869-2878 (1995).
4. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N. Engl. J. Med. 333, 1444-1455 (1995).
5. Early Breast Cancer Tralists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 355, 1757-1770 (2000).
6. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother. Oncol. 55(3), 263-272 (2000).
7. Overgaard M, Hansen PS, Overgaard J et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Co-operative Group 82b Trial. N. Engl. J. Med. 337, 949-955 (1997).
8. Ragaz J, Jackson SM, Le N et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 337, 956-962 (1997).
9. Overgaard M, Jensen MB, Overgaard J et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Co-operative Group 82c randomized trial. Lancet 353, 1641-1648 (1999).
10. Ragaz J, Olivotto IA, Spinelli JJ et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 97(2), 116-126 (2005).
11. Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet 354(9188), 1425-1430 (1999).
12. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiotherapy improve survival in breast cancer? A meta-analysis. J. Clin. Oncol. 18, 1220-1229 (2000).
13. Hellman S. Stopping metastases at their source. N. Engl. J. Med. 337, 996-997 (1997).
14. Fowble B, Gray R, Gilchrist K et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 6, 1107-1117 (1998).
15. Pisansky TM, Ingle JN, Schaid DJ et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node-positive breast cancer. Impact of clinical, histopathologic, and flow cytometric factors. Cancer 72(4), 1247-1260 (1993).
16. Recht A, Gray R, Davidson NE et al. Locoregional failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 17, 1689-1700 (1999).
17. Katz A, Strom EA, Buchholz TA et al. Loco-regional recurrence patterns following mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J. Clin. Oncol. 18(15), 2817-2827 (2000).
18. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 50(3), 735-742 (2001).
19. Katz A, Buchholz TA, Thames HD et al. Recursive partitioning analysis of locoreglonal recurrence following mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. Int. J. Radiat. Oncol. Biol. Phys. 50(2), 397-403 (2001).
20. Wallgren A, Bonetti M, Gelber RD et al. International Breast Cancer Study Group Trials I through VII. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J. Clin. Oncol. 21(7), 1205-1213 (2003).
21. Taghian AG, Jeong JH, Mamounas E et al. Pattern of loco-regional and distant failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J. Clin. Oncol. 22(21), 4247-4254 (2004).
22. Harris JR, Halpin-Murphy P, McNeese M et al. Consensus statement on postmastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 44(5), 989-990 (1999).
23. Recht A, Edge SB, Solin LJ et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19(5), 1539-1569 (2001).
24. Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: postmastectomy locoregional radiotherapy. For the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 170(8), 1263-1273 (2004).
25. Fisher B, Jeong JH, Anderson S et al. Twenty five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N. Engl. J. Med. 347, 567-575 (2002).
26. Cheng JCH, Chen CM, Liu MC et al. Locoregional failure of postmastectomy patients with 1-3 positive lymph nodes without adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 52(4), 980-988 (2002).
27. Fodor J, Polgar C, Major T et al. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation: significance of tumor size. Strahlenther. Onkol. 179, 197-202 (2003).
28. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E. Selecting breast cancer patients with T1-2 tumors and 1-3 positive axillary nodes at high postmastectomy locoregional recurrence risks for adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 61(5), 1337-1347 (2005).
29. Woodward W, Strom EA, Tucker SL et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy radiation: implications for patients with early stage disease and predictors for recurrence after radiation. Int. J. Radiat. Oncol. Biol. Phys. 57, 336-344 (2003).
30. Truong PT, Lesperance M, Culhaci A, Kader HA, Speers CH, Olivotto IA. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 62(1), 175-182 (2005).
31. Jagsi R, Abi Raad R, Goldberg S et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int. J. Radiat. Oncol. Biol. Phys. 62(4), 1035-1039 (2005).
32. Buchholz TA, Tucker SL, Masullo L et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J. Clin. Oncol. 20(1), 17-23 (2002).
33. Buchholz TA, Katz A, Strom EA et al. Pathological factors that predict for local-regional recurrences after mastectomy are different for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 53(4), 880-888 (2002).
34. Huang EH, Tucker SL, Strom EA et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J. Clin. Oncol. 22(23), 4691-4699 (2004).
35. Larson D, Weinstein M, Goldberg I et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 12, 1575-1582 (1986).
36. Hojris I, Andersen J, Overgaard M, Overgaard J. Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol. 39, 355-372 (2000).
37. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 83(Suppl. 12), 2776-2781 (1998).
38. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J. Natl. Cancer Inst. 93(2), 96-111 (2001).
39. Lind PA, Marks LB, Hardenbergh PH et al. Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 52, 137-143 (2002).
40. Yu TK, Whitman GJ, Thames HD et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J. Natl Cancer Inst. 96(22), 1676-1681 (2004).
41. Taghian AG, Assaad SI, Niemierko A et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J. Natl Cancer Inst. 93, 1806-1811 (2001).
42. Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int. J. Radiat. Oncol. Biol. Phys. 62(2), 386-391 (2005).
43. Pierce LJ, Butler JB, Martel MK et al. Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int. J. Radiat. Oncol. Biol. Phys. 52(5), 1220-1230 (2002).
44. Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother. Oncol. 62, 163-171 (2002).
45. Krueger EA, Fraass BA, McShan DL, Marsh R, Pierce LJ. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56(4), 1023-1037 (2003).
46. Cho BC, Schwarz M, Mijnheer BJ, Bartelink H. Simplified intensity-modulated radiotherapy using pre-defined segments to reduce cardiac complications in left-sided breast cancer. Radiother. Oncol. 70(3), 231-241 (2004).
47. Woodward WA, Strom EA, McNeese MD et al. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 327-335 (2003).
48. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J. Natl Cancer Inst. 97(6), 419-424 (2005).
49. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6(8), 557-565 (2005).
50. Shapiro CL, Hardenbergh PH, German R et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J. Clin. Oncol. 16, 3493-3501 (1998).
51. Zambetti M, Moliterni A, Materazzo C et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J. Clin. Oncol. 19, 37-43 (2001).
52. Hardenbergh P, Recht A, Gollamudi S et al. Treatment related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 45, 69-72 (1999).
53. Poortmans P, Kouloulias VE, Venselaar JL et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur. J. Cancer 39(14), 2035-2042 (2003).
54. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J. Natl Cancer Inst. 88, 918-922 (1996).
55. Chawla AK, Kachnic LA, Taghian AG, Niemierko A, Zapton DT, Powell SN. Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. Int. J. Radiat. Oncol. Biol. Phys. 54(2), 520-526 (2002).
56. Alderman AK, Wilkins EG, Lowery JC, Kim M, Davis JA. Determinants of patient satisfaction in postmastectomy breast reconstruction. Plast. Reconstr. Surg. 106(4), 769-776 (2000).
57. Spear SL, Ducic I, Low M, Cuoco F. The effect of radiation on pedicled TRAM flap breast reconstruction: outcomes and implications. Plast. Reconstr. Surg. 115(1), 84-95 (2005).
58. Kronowitz SJ, Hunt KK, Kuerer HM et al. Delayed-immediate breast reconstruction. Plast. Reconstr. Surg. 113(6), 1617-1628 (2004).